Biocryst Pharmaceuticals (BCRX) Current Leases (2017 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Current Leases came in at $1.2 million in Q1 2026, down 31.2% YoY from $1.8 million in Q1 2025, and up 289.59% on a QoQ basis from $317000.0 in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Current Leases (2017 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 10 years of Current Leases data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Current Leases fell 31.2% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 31.2% YoY) and the FY2025 annual result came in at $317000.0, down 82.72% from the prior year.
- Current Leases improved to $1.2 million in Q1 2026, from $317000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.5 million in Q2 2023 to a low of $317000.0 in Q4 2025.
- A 5-year average of $1.5 million and a median of $1.7 million in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases jumped 117.53% — and 2025, when it tumbled 82.72%.
- Tracing BCRX's Current Leases over 5 years: stood at $1.5 million in 2022, then plunged by 30.21% to $1.1 million in 2023, then jumped by 73.44% to $1.8 million in 2024, then plunged by 82.72% to $317000.0 in 2025, then jumped by 289.59% to $1.2 million in 2026.
- The last three Current Leases figures came in at $1.2 million (Q1 2026), $317000.0 (Q4 2025), and $348000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.91 Mn |
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 317,000.00 |
| Sep 30, 2025 | 348,000.00 |
| Jun 30, 2025 | 392,000.00 |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 1.84 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 2.28 Mn |
| Jun 30, 2023 | 2.53 Mn |
| Mar 31, 2023 | 2.49 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | 2.13 Mn |
| Mar 31, 2022 | 2.08 Mn |
| Dec 31, 2021 | 1.82 Mn |
| Sep 30, 2021 | 1.45 Mn |